1. Pulmonary delivery of favipiravir inhalation solution for COVID-19 treatment: in vitro characterization, stability, in vitro cytotoxicity, and antiviral activity using real time cell analysis. (31st December 2022) Authors: Yildiz Pekoz, Ayca; Akbal Dagistan, Ozlem; Fael, Hanan; Culha, Meltem; Erturk, Aybige; Basarir, Nur Sena; Sahin, Gokben; Serhatli, Muge; Cakirca, Gamze; Tekin, Saban; Sen, Leyla Semiha; Sevim, Mustafa; Mulazimoglu Durmusoglu, Lutfiye; Yegen, Berrak C. Journal: Drug delivery Issue: Volume 29:Number 1(2022) Page Start: 2846 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pulmonary delivery of favipiravir inhalation solution for COVID-19 treatment: in vitro characterization, stability, in vitro cytotoxicity, and antiviral activity using real time cell analysis. (31st December 2022) Authors: Yildiz Pekoz, Ayca; Akbal Dagistan, Ozlem; Fael, Hanan; Culha, Meltem; Erturk, Aybige; Basarir, Nur Sena; Sahin, Gokben; Serhatli, Muge; Cakirca, Gamze; Tekin, Saban; Sen, Leyla Semiha; Sevim, Mustafa; Mulazimoglu Durmusoglu, Lutfiye; Yegen, Berrak C. Journal: Drug delivery Issue: Volume 29:Number 1(2022) Page Start: 2846 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗